Clinical Practice Guide: Fever Management in Kawasaki Disease with Coronary Aneurysms
Critical Safety Alert: In a child with Kawasaki disease and known coronary artery aneurysms, the fever curve is a vital sign that dictates pharmacologic management. Independent administration of any antipyretic (e.g., acetaminophen, ibuprofen) is strictly prohibited without a direct physician order, as it can mask the fever and lead to premature or inappropriate de-escalation of high-dose aspirin therapy.
Nursing Priority: The immediate nursing action is to hold any additional antipyretic and urgently consult the treating physician. The physician must be informed of the current temperature and the presence of the aneurysms to make a deliberate decision about fever management that does not compromise the anti-inflammatory or antiplatelet treatment plan.
Rationale for Aspirin Avoidance: The standard of care for acute Kawasaki disease is high-dose aspirin (80-100 mg/kg/day divided every 6 hours) for its anti-inflammatory effect. Once the patient is afebrile for 48-72 hours, the dose is reduced to an antiplatelet dose (3-5 mg/kg/day once daily). This transition point is determined solely by the resolution of fever. Masking the fever with another drug disrupts this critical clinical decision point and places the child at risk for ongoing inflammation or thrombosis.
Supportive Care Guidance: While awaiting physician consultation, provide comfort measures that do not pharmacologically reduce fever. Encourage oral fluid intake to maintain hydration and use lightweight clothing and a neutral thermal environment. Tepid sponge baths may be used only if ordered and if they do not cause shivering, which can paradoxically raise core body temperature.
Thrombosis Risk Context: The presence of a coronary artery aneurysm creates a high-risk state for thrombus formation due to damaged endothelium and activated platelets. The antiplatelet dose of aspirin is a cornerstone of long-term management to prevent myocardial infarction. Any intervention that could inadvertently delay or interrupt this protective therapy must be avoided.